| Characteristics | Study population | Liraglutide | Vildagliptin | P |
| Age M [IQR] | 57 [49 - 61.5] | 57 [41 - 61] | 51 [49 - 63] | 0.74 |
| Sex n (%) |
|
|
| 0.56 |
| Male | 4 | 3 (42.9) | 1 (14.3) |
|
| Female | 10 | 4 (57.1) | 6 (85.7) |
|
| Duration of diabetes |
|
|
| 0.26 |
| <10 ans | 9 | 6 (85.7) | 3 (42.9) |
|
| ≥10 ans | 5 | 1 (14.3) | 4 (57.1) |
|
| Family history of diabetes |
|
|
| 1.00 |
| Yes | 9 | 5 (71.4) | 4 (57.1) |
|
| No | 5 | 2 (28.6) | 3 (42.9) |
|
| Initial treatment |
|
|
| 1.00 |
| Biguanides | 9 | 5 (71.4) | 4 (57.1) |
|
| Biguanides and sulfonylureas | 5 | 2 (28.6) | 3 (42.9) |
|